GLP1R and obesity due to melanocortin 4 receptor deficiency: Of interest, glucagon-like peptide-1 receptor agonists—known for beneficial effects on metabolism and weight control—may also improve depressive symptoms in individuals with diabetes or obesity [47,48], and glucagon-like peptide-1 receptors are stimulated by glutamine [49].